Literature DB >> 24381709

The diagnostic conundrum and treatment dilemma of a patient with a rapidly progressive encephalopathy.

Christopher W Beatty1, Claire J Creutzfeldt2, Arielle P Davis2, Zachary Hoffer3, Sandeep P Khot2.   

Abstract

Entities:  

Keywords:  anti-N-methyl-d-aspartate receptor encephalitis; encephalitis; paraneoplastic; tuberculosis meningoencephalitis

Year:  2014        PMID： 24381709      PMCID： PMC3869309          DOI： 10.1177/1941874413496792

Source DB:  PubMed          Journal:  Neurohospitalist        ISSN： 1941-8744


× No keyword cloud information.
  26 in total

1.  Cognitive deficits following anti-NMDA receptor encephalitis.

Authors:  Carsten Finke; Ute A Kopp; Harald Prüss; Josep Dalmau; Klaus-Peter Wandinger; Christoph J Ploner
Journal:  J Neurol Neurosurg Psychiatry       Date:  2011-09-20       Impact factor: 10.154

2.  The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project.

Authors:  Mary S Gable; Heather Sheriff; Josep Dalmau; Drake H Tilley; Carol A Glaser
Journal:  Clin Infect Dis       Date:  2012-01-26       Impact factor: 9.079

3.  Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.

Authors:  Maarten J Titulaer; Lindsey McCracken; Iñigo Gabilondo; Thaís Armangué; Carol Glaser; Takahiro Iizuka; Lawrence S Honig; Susanne M Benseler; Izumi Kawachi; Eugenia Martinez-Hernandez; Esther Aguilar; Núria Gresa-Arribas; Nicole Ryan-Florance; Abiguei Torrents; Albert Saiz; Myrna R Rosenfeld; Rita Balice-Gordon; Francesc Graus; Josep Dalmau
Journal:  Lancet Neurol       Date:  2013-01-03       Impact factor: 44.182

4.  Meningitis and encephalitis.

Authors:  Karen L Roos; John E Greenlee
Journal:  Continuum (Minneap Minn)       Date:  2011-10

Review 5.  A systematic review of rapid diagnostic tests for the detection of tuberculosis infection.

Authors:  J Dinnes; J Deeks; H Kunst; A Gibson; E Cummins; N Waugh; F Drobniewski; A Lalvani
Journal:  Health Technol Assess       Date:  2007-01       Impact factor: 4.014

6.  Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults.

Authors:  Guy E Thwaites; Duc Bang Nguyen; Huy Dung Nguyen; Thi Quy Hoang; Thi Tuong Oanh Do; Thi Cam Thoa Nguyen; Quang Hien Nguyen; Tri Thuc Nguyen; Ngoc Hai Nguyen; Thi Ngoc Lan Nguyen; Ngoc Lan Nguyen; Hong Duc Nguyen; Ngoc Tuan Vu; Huu Hiep Cao; Thi Hong Chau Tran; Phuong Mai Pham; Thi Dung Nguyen; Kasia Stepniewska; Nicholas J White; Tinh Hien Tran; Jeremy J Farrar
Journal:  N Engl J Med       Date:  2004-10-21       Impact factor: 91.245

7.  Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.

Authors:  Josep Dalmau; Amy J Gleichman; Ethan G Hughes; Jeffrey E Rossi; Xiaoyu Peng; Meizan Lai; Scott K Dessain; Myrna R Rosenfeld; Rita Balice-Gordon; David R Lynch
Journal:  Lancet Neurol       Date:  2008-10-11       Impact factor: 44.182

8.  N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.

Authors:  Sarosh R Irani; Katarzyna Bera; Patrick Waters; Luigi Zuliani; Susan Maxwell; Michael S Zandi; Manuel A Friese; Ian Galea; Dimitri M Kullmann; David Beeson; Bethan Lang; Christian G Bien; Angela Vincent
Journal:  Brain       Date:  2010-06       Impact factor: 13.501

9.  Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal.

Authors:  T Iizuka; F Sakai; T Ide; T Monzen; S Yoshii; M Iigaya; K Suzuki; D R Lynch; N Suzuki; T Hata; J Dalmau
Journal:  Neurology       Date:  2007-09-26       Impact factor: 9.910

10.  Encephalitis with thalamic and basal ganglia abnormalities: etiologies, neuroimaging, and potential role of respiratory viruses.

Authors:  G C Beattie; C A Glaser; H Sheriff; S Messenger; C P Preas; M Shahkarami; A Venkatesan
Journal:  Clin Infect Dis       Date:  2012-11-29       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.